Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

Abroad (travel likely)RecruitingPHASE1

Conditions

Age-Related Macular Degeneration

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Benobio Investigational site, Sydney, New South Wales, Australia
Contact: Study coordinator (jihye choe) · jihye.choe@benobio.com
Sydney Hospital, Sydney, Australia

Study leads

Inhyun Lee, ph.D
Study Chair
Benobio Co., Ltd.

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses

Age Related Macular Degeneration (ARMD) · AMD - Age-Related Macular Degeneration

Abroad (travel likely)RecruitingPHASE1

Dallas, United States

Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Geographic Atrophy · Age-Related Macular Degeneration

Abroad (travel likely)RecruitingPHASE1, PHASE2

Carmel, United States · Reno, United States

Visual Remapping to Aid Reading With Field Loss

Age-related Macular Degeneration

Abroad (travel likely)Recruiting

Minneapolis, United States

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Geographic Atrophy Secondary to Age-related Macular Degeneration

Abroad (travel likely)RecruitingPHASE2

Huntington Beach, United States · Sacramento, United States